Profile picture

Doctor Andre Martins

Leiria Hospital Centre, Leiria (Portugal)
Membership: ESC Professional Member EACVI Member HFA Member
Follow
Logo ESC

Contributor content

Wild-type transthyretin amyloid cardiomyopathy: spironolactone as a therapeutic option?
Presentation
Wild-type transthyretin amyloid cardiomyopathy: spironolactone as a therapeutic option?
Read more
The role of the triglyceride-glucose index as a predictor of coronary artery disease severity in young patients
Presentation
The role of the triglyceride-glucose index as a predictor of coronary artery disease severity in young patients
Read more
Impact of iron deficiency on adverse outcomes in transthyretin cardiac amyloidosis
Presentation
Impact of iron deficiency on adverse outcomes in transthyretin cardiac amyloidosis
Read more
Tafamidis for the treatment of wild-type transthyretin cardiac amyloidosis: insights from a regional hospital experience
Presentation
Tafamidis for the treatment of wild-type transthyretin cardiac amyloidosis: insights from a regional hospital experience
Read more
Gender-related differences in hypertrophic cardiomyopathy: from clinical presentation to outcomes
Presentation
Gender-related differences in hypertrophic cardiomyopathy: from clinical presentation to outcomes
Read more
Genotype-driven differences in the phenotype and prognosis of patients with hypertrophic cardiomyopathy
Presentation
Genotype-driven differences in the phenotype and prognosis of patients with hypertrophic cardiomyopathy
Read more
Predictors of atrial fibrillation in hypertrophic cardiomyopathy: insights from a regional hospital experience
Presentation
Predictors of atrial fibrillation in hypertrophic cardiomyopathy: insights from a regional hospital experience
Read more
Time to consider atrial and diastolic function as key drivers of major adverse cardiovascular events in hypertrophic cardiomyopathy
Presentation
Time to consider atrial and diastolic function as key drivers of major adverse cardiovascular events in hypertrophic cardiomyopathy
Read more
Multiparametric echocardiography scores for transthyretin cardiac amyloidosis diagnosis - is the increased wall thickness score appropriate?
Presentation
Multiparametric echocardiography scores for transthyretin cardiac amyloidosis diagnosis - is the increased wall thickness score appropriate?
Read more
Differentiating transthyretin cardiac amyloidosis among left ventricular hypertrophy phenotypes: the role of right and left ventricular global longitudinal strain
Presentation
Differentiating transthyretin cardiac amyloidosis among left ventricular hypertrophy phenotypes: the role of right and left ventricular global longitudinal strain
Read more

ESC 365 is supported by

novartis Explore sponsored resources